SARS-CoV-2 risk is lower among children aged younger than 5 who had vs did not have prior infection, regardless of vaccination status.
1d
GlobalData on MSNFDA clears Hologic’s Aptima SARS-CoV-2 assayHologic's Panther system, on which the assay runs, processes the samples, delivering initial outcomes in under three hours.
COVID-19 has little impact on patients with dermatological immune-mediated inflammatory diseases, with effective ...
(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. HealthDay News — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is ...
Seasonal influenza has reached its highest levels in over 15 years and has now surpassed COVID-19 deaths for the past two ...
International researchers warn that the ongoing mpox outbreak in the Democratic Republic of the Congo (DRC) has the potential to spread across borders more rapidly. The mpox virus has mutated, and the ...
A new portable and wireless device can detect SARS-CoV-2 and vitamin C, a critical nutrient that helps bolster infection ...
The following is a summary of “Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis,” published in ...
Infection with the SARS-CoV-2 Omicron variant confers weak, short-term protection against reinfection, compared with the much ...
A Weill Cornell Medicine-Qatar study found that SARS-CoV-2 evolved from prioritizing transmission to evading immunity after the Omicron variant emerged. Before Omicron, natural immunity from prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results